Management

Robert B. Jones
President & Chief Executive Officer
Bob has been our President & CEO since July 2011 and served in that capacity on an interim basis since May 2011 after the passing of Andy Reddick in April 2011. Bob previously served as Senior Vice President and Chief Operating Officer since he joined Acura in April 2008. From May, 2003 to March, 2008, Mr. Jones served first as the Vice President, Finance and then as Vice President, Strategy and Business Analysis of Adolor Corporation. From November 2000 to May, 2003 he served as Vice President, Finance and then as Chief Operating Officer of Opt-E-Script, Inc., a privately held personalized medicine company where Mr. Jones was responsible for all commercialization activities. Prior to that, Mr. Jones was Vice President, Sales and Marketing for Purepac Pharmaceutical Company. Mr. Jones received his M.B.A. from the University of North Carolina and a B.S. from Cornell University.
Peter A. Clemens
Senior Vice President, Chief Financial Officer
Pete has been Senior Vice President, Chief Financial Officer and Secretary since April 2004. Mr. Clemens was our Vice President, Chief Financial Officer and Secretary from February 1998 to March 2004 and a member of our Board of Directors from June, 1998 to August, 2004. Mr. Clemens is a Certified Public Accountant and earned a Bachelor of Business Administration degree from the University of Notre Dame and a Masters of Business Administration from Indiana University.
Holdings: 279,523 shares     View Transactions
Date Type Shares Traded Price Range
May 16, 2014 Buy 3,000 1.21
Feb 27, 2014 Disposition (Non Open Market) 6,887 2.03
Feb 27, 2014 Option Execute 9,375 1.30
Jan 1, 2014 Disposition (Non Open Market) 57,491 1.67
Dec 17, 2013 Disposition (Non Open Market) 8,170 1.54
Dec 17, 2013 Option Execute 9,375 1.30
Mar 12, 2012 Sell 10,000 3.86
Jan 1, 2012 Disposition (Non Open Market) 55,242 3.49
Jan 1, 2012 Option Execute 9,375 1.30
Jan 1, 2012 Disposition (Non Open Market) 51,824 2.22
Aug 15, 2011 Buy 2,500 2.68
Aug 12, 2011 Buy 1,000 2.65
Jan 26, 2011 Buy 350 2.98
Jan 25, 2011 Option Execute 9,375 1.30
Jan 1, 2011 Disposition (Non Open Market) 47,268 3.31
James F. Emigh R.PH.
Vice President, Corporate Development
Jim has been Vice President, Corporate Development since October 2011. Prior to that, Mr. Emigh was our Vice President of Marketing and Administration from April 2004 through September 2011. Mr. Emigh joined the company in May, 1998, serving first as Executive Director of Customer Relations, then as Vice President of Operations until November, 2002, and as Vice President of Sales and Marketing until March 2004. Mr. Emigh holds a Bachelor of Pharmacy degree from Washington State University and a Masters of Business Administration from George Mason University.
Holdings: 198,304 shares     View Transactions
Date Type Shares Traded Price Range
May 16, 2014 Buy 15,000 1.21
Jan 24, 2014 Option Execute 6,225 1.30
May 3, 2013 Option Execute 6,225 1.30
Jan 1, 2013 Disposition (Non Open Market) 6,596 2.22
Jan 27, 2012 Option Execute 6,225 1.30
Aug 12, 2011 Buy 5,000 2.56 - 2.64
Jan 21, 2011 Option Execute 6,225 1.30
Robert A. Seiser CPA
Vice President, Treasurer and Corporate Controller
Bob has been Vice President, Treasurer and Corporate Controller since April 2004. Mr. Seiser joined us in March 1998 as our Treasurer and Corporate Controller. Mr. Seiser is a Certified Public Accountant and earned a Bachelor of Business Administration degree from Loyola University of Chicago.
Holdings: 22,490 shares     View Transactions
Date Type Shares Traded Price Range
Feb 7, 2017 Disposition (Non Open Market) 821 1.30
Feb 7, 2017 Option Execute 1,166 0.92
Jan 16, 2014 Disposition (Non Open Market) 5,141 1.82
Jan 16, 2014 Option Execute 6,225 1.30
Jan 1, 2014 Disposition (Non Open Market) 23,949 1.67
Mar 5, 2013 Disposition (Non Open Market) 3,932 3.04
Mar 5, 2013 Option Execute 6,225 1.30
Jan 1, 2013 Disposition (Non Open Market) 22,211 2.22
May 3, 2012 Disposition (Non Open Market) 3,923 3.07
May 3, 2012 Option Execute 6,225 1.30
Jan 1, 2012 Disposition (Non Open Market) 20,613 3.49
Oct 17, 2011 Disposition (Non Open Market) 3,442 4.72
Oct 17, 2011 Option Execute 6,225 1.30
Jan 1, 2011 Disposition (Non Open Market) 19,897 3.31
Albert W. Brzeczko Ph.D.
Vice President, Technical Affairs

Al has been Vice President, Technical Affairs of Acura Pharmaceutical Technologies, Inc. since February 2009. From 1999 through 2009, Dr. Brzeczko was Vice President, Global Pharma New Product Development and Pharma Technologies for International Specialty Products, Inc., a contract services group specializing in the development of technologies for the bioenhancement of poorly soluble drugs. Prior to 1999, Dr. Brzeczko held various positions of increasing responsibility in pharmaceutical product development with UPM Pharmaceuticals, Banner Pharmacaps, Mylan Laboratories, and DuPont Merck. Dr. Brzeczko received a Bachelor of Science degree in biochemistry and a Ph.D. in pharmaceutical sciences from the University of Maryland.


Holdings: 16,000 shares     View Transactions
Date Type Shares Traded Price Range
Aug 29, 2017 Buy 4,000 0.47 - 0.47
Aug 28, 2017 Buy 2,000 0.45
Aug 25, 2017 Buy 4,800 0.48
May 19, 2014 Buy 2,000 1.20
Nov 25, 2013 Buy 1,215 1.70
May 18, 2012 Buy 1,000 2.55
Jan 1, 2012 Disposition (Non Open Market) 2,215 3.49
J. Bradley Rivet
Vice President, Marketing
Brad has been Vice President of Marketing since October 2011. Before joining Acura, Mr. Rivet was Vice President at Effcon Laboratories, Inc. where he was responsible for OTC product marketing and new product initiatives from concept through commercialization since 1996. Prior to his employment at Effcon, Mr. Rivet was Manager, Advertising and Promotion for aaiPharma in Wilmington, NC. From 1979 to 1994, he held various positions of increasing responsibility in pharmaceutical sales, consumer product marketing and brand management with Burroughs Wellcome Co. Mr. Rivet received a Bachelor of Science degree from Louisiana State University.
Holdings: 2,000 shares     View Transactions
Date Type Shares Traded Price Range
May 19, 2014 Buy 2,000 1.23
Oct 3, 2011 Statement of Ownership 0 n/a
Ronald L. Leech
Senior Director Quality & Analytical Chemistry

Ron has been the Senior Director Quality & Analytical Chemistry of Acura Pharmaceutical Technologies, Inc. since May 2004. Prior to that time he was Director of Analytical Chemistry. Ron's current responsibilities include leadership of the Company's programs for analytical method development and validation, quality control, quality assurance and product stability testing. Prior to joining the company in April 2002 Ron held positions at ILEX Oncology, DPT Laboratories and PPD/Pharmaco. His background includes biopharmaceutical oncology, development of novel dermatological products for use in the field of burn management, contract manufacturing, contract analytical services, and medical devices. Ron holds a BS degree in Biochemistry from Edgewood College in Madison, WI.


John G. Gilkay P.E.
Director of EHS & Engineering

John has been the Director of EHS & Engineering of Acura Pharmaceutical Technologies, Inc. since April 2004. Prior to that time, he was Director Environmental Affairs, Health and Safety at our Culver, Indiana facility. From September 1993 until joining the Company in April 2000 he was employed by Laidlaw Environmental Services/Safety-Kleen managing environmental multimedia, health and safety, and transportation compliance for several facilities in Southern California. John has also held positions with Johnson & Johnson, Merck CPC, W.R. Grace and Angus Biotech in a variety of production, engineering and EHS compliance roles. He is a licensed Professional Engineer and holds a B.S. degree in Chemical Engineering from the University of Wisconsin..


Gregory A. Spinner
Director of Logistics and Special Projects

Greg has been Director of Logistics and Special Projects of Acura Pharmaceutical Technologies, Inc. since April 2004. Prior to that time he served the Company as Director of Supply Chain Management and Financial Controller for operations facilities. Prior to joining the Company in August 1998 Greg was employed by Transfer Drivers, Inc. and Morgan Drive Away, Inc. as an Accountant and Divisional Controller. Greg holds a BA degree in Accounting from Western Michigan University.



Stock transaction information provided by EDGAR Online. Acura Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.